Emcure Seeks Fees After $950M Vax Trade Secrets Suit Nixed
Indian generic-drug maker Emcure Pharmaceuticals Ltd. is now seeking more than $3.2 million in attorney fees after convincing a Washington federal judge to toss on jurisdictional grounds Seattle-based HDT Bio Corp.'s...To view the full article, register now.
Already a subscriber? Click here to view full article